Junqiu Zhai

Dr. Junqiu Zhai

School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2022 in ACS Nano
Verified
Journal Article
Closed access
LZLiuting Zhong
Liuting Zhong
Junqiu ZhaiJunqiu Zhai
Junqiu Zhai
YMYan Ma
Yan Ma
YHYihong Huang
Yihong Huang
YPYongrui Peng
Yongrui Peng
SGShixia Guan
Shixia Guan

25 December 2024 in Advanced Science
Verified
Journal Article
Open access
WHWenjuan Huang
Wenjuan Huang
JWJiaqi Wang
Jiaqi Wang
CWCheng Wang
Cheng Wang
YLYuanfang Liu
Yuanfang Liu
WLWentao Li
Wentao Li
Chaoxing LiuChaoxing Liu
Chaoxing Liu
Precise control of Cas12a activity is essential for the improvement of the detection limit of clinical diagnostics and the minimization of errors. This study addresses the challenge of controlling Cas12a activity, especially in the context of nucleic acid detection where the inherent incompatibility between isothermal amplification and CRISPR reactions complicates accurate diagnostics. An RNA G‐quadruplex (RG4) structure at the 5′ end of crRNA is introduced to modulate Cas12a activity accurately without the need for chemical modifications. The results indicate that the presence of RG4 does not significantly impact Cas12a's cleavage activity but can be controlled by RG4 stabilizers, enabling the suppression and subsequent restoration of Cas12a activity with potential for precise activity control. Moreover, the use of RG4 is expanded by incorporating it into split crRNA, introducing RG4 directly at the 5′ end of the direct repeat (DR) region, enabling tailored activity regulation for different targets by matching with various Spacer regions. Additionally, a light‐controlled one‐pot method for activating Cas12a is developed, thereby enhancing the accuracy and sensitivity of clinical samples. This study showcases the pioneering use of RG4 in manipulating Cas12a activity, streamlining diagnostics, and paving the way for advances in clinical nucleic acid testing.

8 April 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
DZDong-Yang Zhang
Dong-Yang Zhang
FHFanglin Huang
Fanglin Huang
YMYan Ma
Yan Ma
GLGuangzhong Liang
Guangzhong Liang
ZPZhuo Peng
Zhuo Peng
Junqiu ZhaiJunqiu Zhai
Junqiu Zhai

17 February 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
XYXufeng Yang
Xufeng Yang
YPYongrui Peng
Yongrui Peng
YWYu-E Wang
Yu-E Wang
YZYuxiu Zheng
Yuxiu Zheng
YHYiming He
Yiming He
SGShixia Guan
Shixia Guan

22 December 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
YHYiming He
Yiming He
YHYihong Huang
Yihong Huang
HXHuahua Xu
Huahua Xu
XYXufeng Yang
Xufeng Yang
NLNan Liu
Nan Liu
SGShixia Guan
Shixia Guan

21 July 2020 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YMYan Ma
Yan Ma
DZDong-Yang Zhang
Dong-Yang Zhang
ZPZhuo Peng
Zhuo Peng
SGShixia Guan
Shixia Guan
Junqiu ZhaiJunqiu Zhai
Junqiu Zhai